LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged aqua products · clear

PTAB

PTAB Debates Standard for Reasonable Number of Substitute Claims

Rebutting the Presumption of Unreasonability Given the complications associated with amending litigated claims , amendment is still relatively rare at the Patent Trial & Appeal Board (PTAB). Yet, there remain Patent Owners willing to amend claims in…

September 19, 2018·PTAB·6 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.